Portal hypertension in polycystic liver disease patients does not affect wait-list or immediate post-liver transplantation outcomes

Table 2 Comparison of patient demographics between patients with and without portal hypertension

Listing parameter	Portal hypertension (n = 19)	Non-portal hypertension (n = 28)	P value
Age (yr)	50.6 (6.4)	47.1 (7.4)	0.101
Female gender	17 (89.5)	25 (89.3)	0.683
Bilirubin (μmol/L)	8 (6-11)	8 (6-12)	0.965
INR	1.1 (1.0-1.2)	1.1 (1.0-1.1)	0.173
Creatinine (mmol/L)	106 (104-436)	119 (92-201)	0.508
Platelet count (× 109)	177 (147-242)	234 (198-242)	0.012
Sodium (mmol/l)	139 (137-143)	140 (138-142)	0.483
MELD score	12 (9-21)	11 (8-16)	0.422
UKELD score	48 (44-50)	46 (45-48)	0.344
Chronic kidney disease1	16 (84.2)	19 (67.9)	0.179
Dialysis dependant	3 (15.8)	2 (7.1)	0.317

¹Chronic kidney disease defined as stage III-V[17]. INR: International normalized ratio; MELD: Model For End-stage Liver Disease; UKELD: United Kingdom Model for End-Stage Liver Disease.